Clinical Trial Update: Efficacy of Phosphatidylcholine in NAFLD [Phase 3]

View source ↗

Summary

Phase 3 trial assessing phosphatidylcholine for non-alcoholic fatty liver disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• phosphatidylcholine (phosphatidylcholine)

Snippet

Sponsor: Nehal Abou Seada | Conditions: Non-Alcoholic Fatty Liver Disease | Phase 3 | Status: COMPLETED